EFFECT OF BRONCHODILATORS ON HEART RATE VARIABILITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

• Հիմնական հեղինակներ: H. H. Shugushev (Հեղինակ), M. V. Gurizeva (Հեղինակ), V. M. Vasilenko (Հեղինակ)
• Ձևաչափ: Գիրք
• Հրապարակվել է: Столичная издательская компания, 2015-12-01T00:00:00Z.
• Խորագրեր: article
• Առցանց հասանելիություն: Connect to this object online.
• Notes: 1819-6446; 2225-3653; 10.1234/1819-6446-2007-4-51-54
• Keywords: хроническая обструктивная болезнь легких; аритмия; бронхолитическая терапия; Therapeutics. Pharmacology; RM1-950; Diseases of the circulatory (Cardiovascular) system; RC666-701
• Source: Рациональная фармакотерапия в кардиологии, Vol 3, Iss 4, Pp 51-54 (2015)

<p><strong>Aim.</strong> To study effect of long-acting theophylline (Theotard, KRKA) and combination of salmeterol and fluticasone (Seretide, GlaxoSmithKline) on heart rhythm variability (HRV) and number of arrhythmic episodes in patients with chronic obstructive pulmonary disease (COPD).</p><p><strong>Material and methods.</strong> 144 patients with COPD and 35 patients of control group were examined. The analysis of HRV and Holter monitoring were made f on 2th and 14th days.</p><p><strong>Results.</strong> Treatment with both drugs led to increase in power of low- and high frequencies and their ratio (LF/HF), decrease in rate of supraventricular and ventricular arrhythmias. Theophylline therapy raised in a number of single and pair supraventricular extrasystoles. Treatment with combination of salmeterol and fluticasone did not change a number of extrasystoles.</p><p><strong>Conclusion.</strong> Combination of salmeterol and fluticasone is more preferable as a broncholytic therapy for patients with COPD and heart rhythm disorders.</p>